NewsRx

Search our medical news database

Blood Safety

U.S. National Institutes of Health awards grant for clinical trial of bacterial test

Published in Hospital Business Week, November 19th, 2006

Immunetics, Inc. has received a $2.5 million grant from the National Heart, Lung and Blood Institute to support clinical trials for its BacTx test for bacterial contamination of platelet units.

The award is a continuation of earlier grants from the National Institutes of Health (NIH) that supported the development of this test. The NIH grant is intended to help the company obtain U.S. Food & Drug Administration (FDA) approval and bring the product to market. Transfusion of bacterially contaminated platelets can result in severe or fatal sepsis, and remains the highest known risk associated with transfusion of blood products.

Screening all platelet...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook